{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:09:38Z","timestamp":1793459378204,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL165798"],"award-info":[{"award-number":["R01HL165798"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA230631"],"award-info":[{"award-number":["R01CA230631"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA259581"],"award-info":[{"award-number":["R01CA259581"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK111430"],"award-info":[{"award-number":["R01DK111430"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.exphem.2024.104153","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T09:46:22Z","timestamp":1705484782000},"page":"104153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Metabolic regulation of erythrocyte development and disorders"],"prefix":"10.1016","volume":"131","author":[{"given":"Junhua","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4587-1622","authenticated-orcid":false,"given":"Min","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-7337","authenticated-orcid":false,"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104153_bib0001","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MOH.0b013e3282f97ae1","article-title":"Ontogeny of erythropoiesis","volume":"15","author":"Palis","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0003","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/metabo13070793","article-title":"Red blood cell metabolism in vivo and in vitro","volume":"13","author":"D'Alessandro","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.exphem.2024.104153_bib0004","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.3814","article-title":"Anemia: progress in molecular mechanisms and therapies","volume":"21","author":"Sankaran","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2023.05.001","article-title":"Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage","volume":"123","author":"Schippel","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2008.07091.x","article-title":"Disorders of red cell membrane","volume":"141","author":"An","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0007","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood-2005-04-1622","article-title":"The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis","volume":"106","author":"van Wijk","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0008","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOH.0000000000000234","article-title":"Metabolic regulation of hematopoietic stem cell commitment and erythroid differentiation","volume":"23","author":"Oburoglu","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0009","doi-asserted-by":"crossref","first-page":"31087","DOI":"10.1074\/jbc.R110.159079","article-title":"GATA switches as developmental drivers","volume":"285","author":"Bresnick","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2024.104153_bib0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.1207306","article-title":"Global DNA demethylation during mouse erythropoiesis in vivo","volume":"334","author":"Shearstone","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.exphem.2024.104153_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.805265","article-title":"Epigenetic and transcriptional control of erythropoiesis","volume":"13","author":"Wells","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.exphem.2024.104153_bib0012","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.2021011044","article-title":"Molecular and cellular mechanisms that regulate human erythropoiesis","volume":"139","author":"Caulier","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0013","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0014","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1alpha level is essential for hematopoietic stem cells","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41586-020-1971-z","article-title":"Live-animal imaging of native haematopoietic stem and progenitor cells","volume":"578","author":"Christodoulou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104153_bib0016","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2018-10-808873","article-title":"Mitochondria in the maintenance of hematopoietic stem cells: new perspectives and opportunities","volume":"133","author":"Filippi","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0017","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1084\/jem.20081297","article-title":"TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species","volume":"205","author":"Chen","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0018","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.stem.2010.09.015","article-title":"mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion","volume":"7","author":"Lee","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0019","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1038\/ncomms13125","article-title":"Specification of haematopoietic stem cell fate via modulation of mitochondrial activity","volume":"7","author":"Vannini","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104153_bib0020","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/emboj.2010.292","article-title":"ROS-mediated amplification of AKT\/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-\/-) mice","volume":"29","author":"Yalcin","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2024.104153_bib0021","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ncb3527","article-title":"Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation","volume":"19","author":"Liu","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2024.104153_bib0022","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ncb3529","article-title":"The mitochondrial respiratory chain is essential for haematopoietic stem cell function","volume":"19","author":"Ans\u00f3","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2024.104153_bib0023","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature13981","article-title":"Intracellular \u03b1-ketoglutarate maintains the pluripotency of embryonic stem cells","volume":"518","author":"Carey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104153_bib0024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","article-title":"Metabolic signatures of cancer cells and stem cells","volume":"1","author":"Intlekofer","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.exphem.2024.104153_bib0025","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/2159-8290.CD-19-0152","article-title":"Loss of EZH2 reprograms BCAA metabolism to drive leukemic transformation","volume":"9","author":"Gu","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2024.104153_bib0026","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1126\/science.aaz2740","article-title":"Cell-specific transcriptional control of mitochondrial metabolism by TIF1\u03b3 drives erythropoiesis","volume":"372","author":"Rossmann","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.exphem.2024.104153_bib0027","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/bloodadvances.2021005975","article-title":"Circulating primitive murine erythroblasts undergo complex proteomic and metabolomic changes during terminal maturation","volume":"6","author":"Nemkov","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104153_bib0028","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/bloodadvances.2021004259","article-title":"Mitochondrial localization and moderated activity are key to murine erythroid enucleation","volume":"5","author":"Liang","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104153_bib0029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MOH.0000000000000707","article-title":"Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis","volume":"29","author":"Ren","year":"2022","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exphem.2017.02.003","article-title":"Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease","volume":"50","author":"Jagadeeswaran","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0031","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjh.18287","article-title":"Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease","volume":"198","author":"Moriconi","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0032","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","article-title":"Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE","volume":"184","author":"Caielli","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0033","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.stem.2014.06.002","article-title":"Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification","volume":"15","author":"Oburoglu","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0034","first-page":"2520","article-title":"Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A","volume":"141","author":"Gonzalez-Menendez","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MOH.0b013e328351c48b","article-title":"Heme metabolism and erythropoiesis","volume":"19","author":"Chung","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0036","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood-2018-01-829036","article-title":"Glutamine via \u03b1-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis","volume":"132","author":"Burch","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0037","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"MTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0038","doi-asserted-by":"crossref","first-page":"ra34","DOI":"10.1126\/scisignal.aaa5903","article-title":"The mTORC1\/4E-BP pathway coordinates hemoglobin production with L-leucine availability","volume":"8","author":"Chung","year":"2015","journal-title":"Sci Signal"},{"key":"10.1016\/j.exphem.2024.104153_bib0039","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ajh.23786","article-title":"FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis","volume":"89","author":"Zhang","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0040","doi-asserted-by":"crossref","first-page":"e01913","DOI":"10.7554\/eLife.01913","article-title":"A critical role for mTORC1 in erythropoiesis and anemia","volume":"3","author":"Knight","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.exphem.2024.104153_bib0041","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.500","article-title":"Chemical modulators of autophagy as biological probes and potential therapeutics","volume":"7","author":"Fleming","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2024.104153_bib0042","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0043","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature03887","article-title":"Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis","volume":"436","author":"Wingert","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104153_bib0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2018-07-815928","article-title":"Iron metabolism under conditions of ineffective erythropoiesis in \u03b2-thalassemia","volume":"133","author":"Rivella","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fphar.2014.00176","article-title":"The IRP\/IRE system in vivo: insights from mouse models","volume":"5","author":"Wilkinson","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.exphem.2024.104153_bib0046","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1093\/emboj\/cdf516","article-title":"Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene","volume":"21","author":"Sun","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2024.104153_bib0047","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.devcel.2018.07.022","article-title":"GATA\/heme multi-omics reveals a trace metal-dependent cellular differentiation mechanism","volume":"46","author":"Tanimura","year":"2018","journal-title":"Dev Cell"},{"key":"10.1016\/j.exphem.2024.104153_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107832","article-title":"Discovering how heme controls genome function through heme-omics","volume":"31","author":"Liao","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2024.104153_bib0049","article-title":"Fine-tuning of cholesterol homeostasis controls erythroid differentiation","volume":"9","author":"Lu","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.exphem.2024.104153_bib0050","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2018-03-838516","article-title":"Enhanced phosphocholine metabolism is essential for terminal erythropoiesis","volume":"131","author":"Huang","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0051","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e3280de2bf1","article-title":"Molecular insights into stress erythropoiesis","volume":"14","author":"Socolovsky","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0052","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exphem.2020.07.011","article-title":"Stress erythropoiesis: definitions and models for its study","volume":"89","author":"Paulson","year":"2020","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0053","article-title":"Metabolic regulation of stress erythropoiesis, outstanding questions, and possible paradigms","volume":"13","author":"Ruan","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.exphem.2024.104153_bib0054","doi-asserted-by":"crossref","first-page":"14473","DOI":"10.1002\/jcp.28228","article-title":"Hexose monophosphate shunt, the role of its metabolites and associated disorders: a review","volume":"234","author":"Akram","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2024.104153_bib0055","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1182\/blood-2008-07-161166","article-title":"Red cell membrane: past, present, and future","volume":"112","author":"Mohandas","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0056","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood.V83.8.2311.2311","article-title":"Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish","volume":"83","author":"Kanno","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0057","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.2019000945","article-title":"Management of pyruvate kinase deficiency in children and adults","volume":"136","author":"Grace","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0058","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0059","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/0003-4819-103-2-245","article-title":"Hemolytic anemias and erythrocyte enzymopathies","volume":"103","author":"Valentine","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MOH.0000000000000574","article-title":"Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia","volume":"27","author":"D'Alessandro","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0061","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajh.26923","article-title":"In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction","volume":"98","author":"D'Alessandro","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0062","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1038\/ncomms12086","article-title":"Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia","volume":"7","author":"Sun","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104153_bib0063","doi-asserted-by":"crossref","first-page":"15281","DOI":"10.1038\/s41598-017-13667-8","article-title":"Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic metabolic reprogramming in sickle cell disease","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2024.104153_bib0064","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1182\/blood-2010-07-299636","article-title":"Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome","volume":"117","author":"Darghouth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(11)60283-3","article-title":"Thalassaemia","volume":"379","author":"Higgs","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2024.104153_bib0066","first-page":"42249","article-title":"\u03b2-thalassemia patients revealed a significant change of untargeted Metabolites in Comparison to","volume":"7","author":"Musharraf","year":"2017","journal-title":"Healthy Individuals. Sci Rep."},{"key":"10.1016\/j.exphem.2024.104153_bib0067","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of LentiGlobin for sickle cell disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0068","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2029392","article-title":"Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease","volume":"384","author":"Esrick","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0069","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0070","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the treatment of sickle cell anemia","volume":"358","author":"Platt","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0071","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104153_bib0072","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A Phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0073","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A Phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0074","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood-2018-03-834440","article-title":"l-glutamine for sickle cell anemia: more questions than answers","volume":"132","author":"Quinn","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0076","doi-asserted-by":"crossref","first-page":"7448","DOI":"10.3390\/ijms23137448","article-title":"Metabolic reprogramming in sickle cell diseases: pathophysiology and drug discovery opportunities","volume":"23","author":"Alramadhani","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2024.104153_bib0077","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V85.11.3289.bloodjournal85113289","article-title":"Antisickling effects of 2,3-diphosphoglycerate depletion","volume":"85","author":"Poillon","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0078","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.hoc.2013.11.001","article-title":"Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin","volume":"28","author":"Safo","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.exphem.2024.104153_bib0079","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa2116634","article-title":"Mitapivat versus Placebo for pyruvate kinase deficiency","volume":"386","author":"Al-Samkari","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0080","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2352-3026(22)00214-9","article-title":"Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial","volume":"9","author":"Glenth\u00f8j","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.exphem.2024.104153_bib0081","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/blood-2016-11-753525","article-title":"AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency","volume":"130","author":"Kung","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0082","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood.2022015403","article-title":"A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease","volume":"140","author":"Xu","year":"2022","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.exphem.2024.104153_bib0083","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2019-121889","article-title":"Phase 1 single (SAD) and multiple ascending dose (MAD) studies of the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of FT-4202, an allosteric activator of pyruvate kinase-R, in healthy and sickle cell disease subjects","volume":"134","author":"Kalfa","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0084","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood.2021011045","article-title":"Ineffective erythropoiesis and its treatment","volume":"139","author":"Cazzola","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0085","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent \u03b2-thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0086","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","article-title":"Transforming growth factor-\u03b2 superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis","volume":"20","author":"Suragani","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0087","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm.3468","article-title":"An activin receptor IIA ligand trap corrects ineffective erythropoiesis in \u03b2-thalassemia","volume":"20","author":"Dussiot","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0088","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0089","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144206","article-title":"The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a \u03b2-thalassemia mouse model","volume":"131","author":"Matte","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104153_bib0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(22)01337-X","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent \u03b1-thalassaemia or \u03b2-thalassaemia: an open-label, multicentre, phase 2 study","volume":"400","author":"Kuo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2024.104153_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100790","article-title":"Right in time: mitapivat for the treatment of anemia in \u03b1- and \u03b2-thalassemia","volume":"3","author":"Musallam","year":"2022","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.exphem.2024.104153_bib0092","doi-asserted-by":"crossref","first-page":"eaav4881","DOI":"10.1126\/scitranslmed.aav4881","article-title":"The autophagy-activating kinase ULK1 mediates clearance of free \u03b1-globin in \u03b2-thalassemia","volume":"11","author":"Lechauve","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2024.104153_bib0093","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1182\/blood.2022017265","article-title":"Loss of miR-144\/451 alleviates \u03b2-thalassemia by stimulating ULK1-mediated autophagy of free \u03b1-globin","volume":"142","author":"Keith","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104153_bib0094","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2024.104153_bib0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci Adv."},{"key":"10.1016\/j.exphem.2024.104153_bib0096","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-cancerbio-050216-121954","article-title":"Analyzing tumor metabolism in vivo","volume":"1","author":"Faubert","year":"2017","journal-title":"Annu Rev Cancer Biol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T15:17:41Z","timestamp":1728400661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":96,"alternative-id":["S0301472X24000080"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104153","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic regulation of erythrocyte development and disorders","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104153"}}